AR010289A1 - Derivados de piperidina, procedimiento para su preparacion, formulaciones farmaceuticas que contienen los derivados y su uso en el tratamiento dedesordenes psicoticos - Google Patents

Derivados de piperidina, procedimiento para su preparacion, formulaciones farmaceuticas que contienen los derivados y su uso en el tratamiento dedesordenes psicoticos

Info

Publication number
AR010289A1
AR010289A1 ARP970105310A ARP970105310A AR010289A1 AR 010289 A1 AR010289 A1 AR 010289A1 AR P970105310 A ARP970105310 A AR P970105310A AR P970105310 A ARP970105310 A AR P970105310A AR 010289 A1 AR010289 A1 AR 010289A1
Authority
AR
Argentina
Prior art keywords
derivatives
preparation
treatment
pharmaceutical formulations
formulations containing
Prior art date
Application number
ARP970105310A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of AR010289A1 publication Critical patent/AR010289A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Derivados de piperidina que comprende la formula (I) donde R1 es benzotienilo, benzofuranilo o naftilo (donde la porcion de benzotienilo,benzofuranilo o naftilo puede ser opcionalmente sustituído por uno o más sustituyentesseleccio nados de halogeno, alcoxi C1-6 alquilo C1-6 y alqueniloC1-6, tienilo sustituido o furanilo sustituído (donde la porcion de tienilo o de furanilo es sustituído por uno o más sustituyentes seleccionados de halogeno, alquilo C1-6cicloalquilo C3-6 y a lquenilo C1-6; R2 es halogeno y R3 es alquilo C1-6, cicloalquilmetilo C3-6 o una sal o solvato de los mismosfarmaceuticamente aceptable, procedimiento para su preparacion, formulaciones farmaceuticas que contienendichos derivados y su uso en el tratamiento dedesordenes psicoticos.
ARP970105310A 1996-11-14 1997-11-13 Derivados de piperidina, procedimiento para su preparacion, formulaciones farmaceuticas que contienen los derivados y su uso en el tratamiento dedesordenes psicoticos AR010289A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96203175 1996-11-14

Publications (1)

Publication Number Publication Date
AR010289A1 true AR010289A1 (es) 2000-06-07

Family

ID=8224578

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105310A AR010289A1 (es) 1996-11-14 1997-11-13 Derivados de piperidina, procedimiento para su preparacion, formulaciones farmaceuticas que contienen los derivados y su uso en el tratamiento dedesordenes psicoticos

Country Status (20)

Country Link
US (1) US6288085B1 (es)
EP (1) EP0941225A1 (es)
JP (1) JP2001508044A (es)
KR (1) KR20000053217A (es)
CN (1) CN1092655C (es)
AR (1) AR010289A1 (es)
AU (1) AU722224B2 (es)
BR (1) BR9713044A (es)
CA (1) CA2271832A1 (es)
CZ (1) CZ172399A3 (es)
HU (1) HUP9904526A3 (es)
IL (1) IL122072A (es)
NO (1) NO992302L (es)
NZ (1) NZ335631A (es)
PL (1) PL333323A1 (es)
RU (1) RU2183624C2 (es)
TR (1) TR199901385T2 (es)
TW (1) TW374085B (es)
WO (1) WO1998021206A1 (es)
ZA (1) ZA979781B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2716599A (en) * 1998-01-09 1999-07-26 Akzo Nobel N.V. Use of phenylthienylmethylene piperidine derivative in the manufacture of a medicament for the treatment of movement disorders
WO1999034802A1 (en) * 1998-01-09 1999-07-15 Akzo Nobel N.V. Use of phenylthienylmethylene piperidine derivatives in the manufacture of a medicament for the treatment of depression
KR20050085673A (ko) * 2002-12-18 2005-08-29 에프엠씨 코포레이션 Ｎ-(치환된 아릴메틸)-4-(이치환된 메틸)피페리딘 및피페라진
MXPA06014574A (es) * 2004-06-24 2007-03-12 Incyte Corp Piperidinas n-sustituidas y su uso como farmaceuticos.
JP2008504279A (ja) * 2004-06-24 2008-02-14 インサイト・コーポレイション アミド化合物およびその医薬としての使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL88235C (es) 1950-12-05
GB1242169A (en) * 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives
GB1320481A (en) * 1971-01-11 1973-06-13 Pfizer Ltd Substituted gem-diaryl ethylene derivatives and therapeutic compositions thereof
CH587845A5 (en) * 1973-07-17 1977-05-13 Sandoz Ag New piperidylidene-benzo-cyclohepta-thiophenes prodn. - by dehydrating corresp. alcohols, useful e.g. as neuroleptics and analgesics
US4073912A (en) * 1976-10-12 1978-02-14 Smithkline Corporation Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins and antipsychotic use thereof
US4485107A (en) 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4797489A (en) * 1987-12-02 1989-01-10 American Home Products Corp. Adamantyl- and fluorenyl-arylpiperazines and -arylpiperidines
GB8900382D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
DE69123090D1 (de) * 1990-07-06 1996-12-19 Yoshitomi Pharmaceutical Kondensierte Thiophenverbindungen und deren Verwendung
US5683998A (en) * 1991-04-23 1997-11-04 Toray Industries, Inc. Tricyclic triazolo derivatives, processes for producing the same and the uses of the same

Also Published As

Publication number Publication date
NZ335631A (en) 2000-10-27
IL122072A0 (en) 1998-03-10
IL122072A (en) 2001-03-19
CN1092655C (zh) 2002-10-16
PL333323A1 (en) 1999-12-06
TW374085B (en) 1999-11-11
CA2271832A1 (en) 1998-05-22
CN1240444A (zh) 2000-01-05
EP0941225A1 (en) 1999-09-15
AU722224B2 (en) 2000-07-27
AU5552098A (en) 1998-06-03
JP2001508044A (ja) 2001-06-19
HUP9904526A3 (en) 2000-12-28
WO1998021206A1 (en) 1998-05-22
US6288085B1 (en) 2001-09-11
ZA979781B (en) 1998-06-08
CZ172399A3 (cs) 1999-11-17
HUP9904526A2 (hu) 2000-11-28
TR199901385T2 (xx) 1999-11-22
BR9713044A (pt) 2000-04-11
NO992302D0 (no) 1999-05-12
NO992302L (no) 1999-05-14
KR20000053217A (ko) 2000-08-25
RU2183624C2 (ru) 2002-06-20

Similar Documents

Publication Publication Date Title
LTC1265862I2 (lt) 2-Okso-1-pirolidino dariniai, jų gamybos būdas ir jų panaudojimas
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
KR910002444A (ko) 스피로사이클릭 피페리딘 유도체, 이의 제조방법, 이의 용도 및 이를 함유하는 약학 조성물
ES2123829T3 (es) Derivados de 3-(5-tetrazolil-bencil)amino-piperidina y antagonistas de las taquiquininas.
AR031930A1 (es) Antagonistas de mch y su uso en el tratamiento de la obesidad
ES2192264T3 (es) Sal mesilato trihidrato de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2(1h)-indol-2-ona (=ziprasidona), su preparacion y su uso como antagonista de la dopamina.
EE05135B1 (et) Dopamiini neurotransmissiooni modulaatorid, nendekasutamine ja neid hendeid sisaldavad farmatseutilised kompositsioonid
ES2184772T3 (es) Derivados de bifenilo, procedimiento para su preparacion y su utilizacion como medicamentos.
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
NO308248B1 (no) Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat
LU92146I2 (fr) Dasatinib et ses sels pharmaceutiquement acceptables
NO20030744L (no) Nye fenylalaninderivater
PT91126A (pt) Processo para a preparacao de derivados de (1-hidroxi-2-piperidinil-alquil)-2- indolonas, 2-quinoleinonas, benzo {b}-2-azepinonas, 2-benzimidazolonas e 2- -quinazolinonas e de composicoes farmaceuticas que os contem
NO20001736L (no) Hydroksyeddiksyreesterderivater, fremgangsmÕte for deres fremstilling samt anvendelse som syntese-mellomprodukter
MX9201356A (es) Derivados de piperidina, procedimiento para su preparacion y composicion farmaceutica que los contiene.
FR2619111B1 (fr) Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
AR011409A1 (es) Derivados de 16-hidroxi-11-(fenil substituido)-estra-4,9-dieno, su utilizacion, un procedimiento para prepararlos, formulaciones farmaceuticasque comprenden a dichos derivados, y un compuesto utilizable como intermediario para prepararlos
NO324229B1 (no) 2-hydroksymutilinkarbamat-derivater, anvendelse derav, farmasoytisk sammensetning samt fremgangsmate for fremstilling av en slik forbindelse
NO20051958L (no) Forbindelser
AR010289A1 (es) Derivados de piperidina, procedimiento para su preparacion, formulaciones farmaceuticas que contienen los derivados y su uso en el tratamiento dedesordenes psicoticos
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
AR027454A1 (es) Derivados de beta-alanina, utiles como antagonistas de receptores, las composiciones farmaceuticas que las contienen y el uso de los mismos para lapreparacion de medicamentos
ATE406363T1 (de) Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten
ES2172436B1 (es) Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
JPS57501628A (es)

Legal Events

Date Code Title Description
FB Suspension of granting procedure